0002109293-26-000001.txt : 20260217 0002109293-26-000001.hdr.sgml : 20260217 20260217093702 ACCESSION NUMBER: 0002109293-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260217 DATE AS OF CHANGE: 20260217 EFFECTIVENESS DATE: 20260217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accretion Therapeutics, Inc. CENTRAL INDEX KEY: 0002109293 ORGANIZATION NAME: EIN: 413439609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573655 FILM NUMBER: 26637286 BUSINESS ADDRESS: STREET 1: 416 OLD MILL CIR CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 BUSINESS PHONE: 8473233236 MAIL ADDRESS: STREET 1: 416 OLD MILL CIR CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 D 1 primary_doc.xml X0708 D LIVE 0002109293 Accretion Therapeutics, Inc. 416 OLD MILL CIR LINCOLNSHIRE IL ILLINOIS 60069 8473233236 DELAWARE None None Corporation true 2026 David Holecek 416 Old Mill Cir Lincolnshire IL ILLINOIS 60069 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2026-02-04 false true Simple Agreement for Future Equity (SAFE) false 750000 1000000 750000 250000 false 1 0 0 0 false Accretion Therapeutics, Inc. David Holecek David Holecek President 2026-02-04